- CDC calls for increased PrEP awareness for high-risk patients (drugstorenews.com)Daily Pill Can Prevent HIV (cdc.gov)
New data from the Centers for Disease Control and Prevention has the organization urging providers to education themselves about the potential of pre-exposure prophylaxis drugs (PrEP) that can significantly reduce the risk of contracting HIV…Though the once-daily pill —which was approved by the Food and Drug Administration in 2013 and marketed as Truvada (tenofovir/embtricitabine) — can reduce risk of HIV transmission through sexual contact by 90% and the risk among injected drug users by 70%, new information shows that one-in-three primary care doctors and nurses haven’t heard of PrEP…“PrEP isn’t reaching many people who could benefit from it, and many providers remain unaware…“With about 40,000 HIV infections newly diagnosed each year in the U.S., we need to use all available prevention strategies.”
- Doctors, pharmacists, patients urged to use generics medication (reviewjournal.com)Doctors should prescribe generic medications whenever possible rather than more expensive brand name drugs (acponline.org)Improving Adherence to Therapy and Clinical Outcomes While Containing Costs: Opportunities From the Greater Use of Generic Medications: Best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians (annals.org)
Medications won't work if patients don't take them…A national association of doctors this week urged physicians to order generic drugs whenever possible because patients are more likely to fill their prescriptions…Southern Nevada doctors and pharmacists say the report in the Annals of Internal Medicine reinforces what they've seen in their practices over the years…"Cost has a role, clearly, in this lack of adherence," said Dr. Scott Stolte, dean of the College of Pharmacy and a professor of pharmacy practice at Roseman University of Health Sciences…"Most of the time the generic drugs are just as effective as the trademark drugs," said Dr. James Anthony, a family practitioner and member of the Nevada State Board of Osteopathic Medicine. "They're more accepted than…they were 10 years ago."…Doctors say they prefer generic drugs because of the data showing patient outcomes improve, and the cost savings are an added benefit…"Not only are prescription-by-prescription costs going to be lower, but also the overall health care costs are going to be lower,"…
- U.K. to Give `Tampon Tax’ to Women’s Cancer and Abuse Charities (bloomberg.com)
U.K. will give taxes raised from the sale of tampons and sanitary towels to women’s charities, Chancellor of the Exchequer George Osborne announced…Money raised from the 5 percent value-added tax on sanitary products will go to cancer charities The Eve Appeal and The Haven and to SafeLives and Women’s Aid, which are dedicated to ending domestic abuse,...Britain will negotiate with the European Union to scrap the tax…“We already charge the lowest 5 percent rate allowable under European law and we’re committed to getting the EU rules changed,” Osborne said in his Autumn Statement to Parliament in London Wednesday. “Until that happens, I’m going to use the 15 million pounds a year raised from the tampon tax to fund women’s health and support charities.”…More than 270,000 people have signed a petition calling for the tax to be removed. It is imposed because the products are defined as “non-essential luxury items” and, while it was reduced to 5 percent...EU law currently prohibits a zero rating.
- Are providers in for a rude awakening about ICD-10? (revenuecycleinsights.com)ICD-10 problems persist for some healthcare providers (revenuecycleinsights.com)
It’s far too early to declare with certainty the impact of the ICD-10 transition on healthcare revenue cycles and productivity…Initial data shows the apocalyptic warnings about ICD-10 immediately leading to claims rejection chaos were misplaced. The Centers for Medicare and Medicaid Services late last month said invalid ICD-10 codes comprised only 0.09% of error-based denials from October 1 through October 27…While CMS said it was “pleased to report that claims are processing normally,” it’s worth keeping in mind that the government agency has taken several temporary steps to smooth the transition to ICD-10 which may be masking problems that could manifest themselves down the road, including a claims denial amnesty for 12 months and advance payments to physicians in the event of processing problems related to ICD-10… Providers that considered themselves unprepared for ICD-10 as October 1 approached shouldn’t assume their currently low claims rejection rates mean their self-assessment was overly pessimistic. If they felt they were unprepared, they probably were. And if they were unprepared for ICD-10 on October 1, they probably still are…To avoid an unpleasant reality check down the road, providers with any doubts about their ICD-10 readiness should continue training and testing.
- Obamacare to blame for soaring drug costs: AEI (cnbc.com)
Americans concerned about not being able to afford life-saving treatments should not blame drug companies for high prices…Dr. Scott Gottlieb…told CNBC's "Squawk Box" there's not really a drug cost problem in the U.S., except for a small subset of specialty drugs that cost a lot but are providing a lot of benefit…"What we have is an under-insurance problem," he said. "People are now under-insured, especially for catastrophic drugs if they get a disease like cancer or something like that because of these new [narrow] formulary designs…popularized by the Affordable Care Act."..."If the drug is not on your [Obamacare] formulary list, you have no co-insurance. You're completely on your own,"…"Since these plans are the predominant structures in Obamacare, they're starting to migrate into commercial plans" in the workplace…
- Healthcare industry says it struggles to define value (mmm-online.com)
Value-based care represents a new set of strategies that aim to reduce wasteful healthcare spending. It includes replacing branded drugs with cheaper generics, using financial incentives to encourage the use of certain drugs on a payer's formulary and insurers electing to cover certain prescription drugs at a lower co-pay…value-based approaches to addressing rising drugs are a possible lever for reducing wasteful healthcare spending—but defining value for payers, drugmakers and patients remains a serious obstacle to adoption…“We don't have a common definition of ‘value-based.' Every other industry has figured out how to do this in a free-market system…Drug pricing has hit an inflection point...There has been new scrutiny from lawmakers and presidential candidates over how drugmakers price their medicines…Some pharma companies have started to publicly discuss new strategies such as risk-sharing or value-based pricing that would support giving high prices for innovative new therapies…pharma needs to show leadership in moderating the prices of established products.
- Junior doctors’ strike: what should patients do? (telegraph.co.uk)Doctors 'naive' to think no harm will come to patients during strikes, says Harvard (telegraph.co.uk)Imposition threat must be removed to defer juniors' action, says BMA (bma.org.uk)
Junior doctors are due to start a series of strikes starting on December 1st, with two days of full walk-out on December 8 and December 15th… December could see the first ever full walk-outs by doctors in the history of the NHS…Following a ballot by the British Medical Association, junior doctors will provide "emergency care only" action for 24 hours on December 1, followed by a full walk out from 8am to 5pm on December 8 and December 16…Hospitals will be forced to cancel most planned operations and outpatients appointments, and to roster as many senior doctors as possible to cover emergency care. On Wednesday, the Health Secretary agreed to send health officials into talks via Acas, which the BMA welcomed - raising the prospect that the strikes could be called off…the union said it would not call off three days of strikes - due to start on December 1 - unless the Government went further, removing threats to impose a new contract on junior doctors if agreement cannot be reached.
- Technology Connects Nevada Specialists With Rural Doctors (kunr.org)Project ECHO (medicine.nevada.edu)
Video technology makes it possible for an urban specialist to see rural patients without anyone having to drive, but it doesn't solve a key underlying issue: there aren’t enough specialists in Nevada…a liver specialist in New Mexico posed this question: What if we used teleconferencing to train primary physicians in rural counties?...The result was Project ECHO, which created a model for other rural health programs in the country, including Nevada in 2012. The local Project ECHO program is run out of the University of Nevada, Reno. According to director Dr. Evan Klass, the program is helping to address doctor shortages…Next up? An expansion into Nevada's urban health centers, which Klass says tend to need just as much help as their rural counterparts these days.
- One in Four Americans Has Been Addicted to Painkillers or Is Close to an Addict (bloomberg.com)
New data show the staggering reach of the prescription drug epidemic...Doctors wrote 259 million opioid prescriptions for Americans in 2012, enough to medicate every adult in the country. Drug overdoses are eclipsing car crashes as a leading cause of accidental death for American adults…A poll out today from the Kaiser Family Foundation adds a troubling new number to the accounting: 27 percent of Americans report that they either have been addicted to prescription painkillers or have a family member or close friend who has…That's roughly 66 million U.S. adults for whom the opioid crisis has become intensely personal…Prescription drug addiction and a related heroin epidemic have proven a stubborn public health crisis since painkiller abuse began rising more than a decade ago…Kaiser's poll found strong majorities in support of policy solutions, including drug treatment, tighter scrutiny of prescribers, and "good samaritan" laws that protect drug users from being charged if they call for help when addicts overdose.
- Amid Growing Rx Costs, No Consensus on Addressing Access (realclearhealth.com)
…stakeholders gathered at HHS' Pharmaceutical Forum…CMS Acting Administrator Andy Slavitt said millions of Medicare and Medicaid beneficiaries, as well as individuals enrolled in the Children's Health Insurance Program or health plans through the Affordable Care Act's insurance exchanges, "rely on prescription medications to manage chronic illnesses and treat acute conditions." However, surveys have shown "that as costs go up, so does everyone's anxiety about their continued access to their prescription medicine," he said…"As we encourage the development of new generations of highly targeted, personalized therapies, we need strategies for ensuring access to these innovations."
Laying Out the Problem
What's Been Proposed?
Negotiating Drug Prices, Increasing Rebates in Medicare
Cost-Sharing Caps
Expediting Drug Approval
Reforming Specialty Drug Reimbursements
No Consensus on Which Plan To Choose









